The Impact of Rising Insulin Costs on Diabetes Management
Financial Barriers for Diabetic Patients
The increasing cost of insulin presents a significant challenge for individuals living with diabetes, leading many to limit their use of this essential medication. A recent study conducted at the Yale Diabetes Center indicates that underutilization of insulin due to cost may be more prevalent than previously understood. Over the last decade, insulin prices in the United States have surged, tripling during this period. Reports of patients rationing their insulin are frequent, and the stakes are particularly high for life-saving medications.
Study Overview and Findings
The extent to which financial constraints affect diabetes management remains inadequately documented. Researchers at Yale University aimed to explore the prevalence of cost-related non-adherence to insulin, with findings published in JAMA Internal Medicine. The study involved a survey of nearly 200 diabetic patients at the Yale Diabetes Center in New Haven, Connecticut. Participants were asked whether they had underused their prescribed insulin over the past year due to cost concerns. The definition of underuse included actions such as taking lower doses than prescribed, not filling prescriptions, not initiating insulin therapy, or discontinuing its use.
The results revealed that around 25% of participants reported cost-related underuse, with this issue being more pronounced among those with lower self-reported incomes. Furthermore, patients who underused insulin were more likely to exhibit poor glycemic control. Notably, about 60% of those who reduced their insulin usage discussed their financial struggles with their healthcare providers. Among those reporting underuse, approximately one-third requested changes to their insulin prescriptions in favor of more affordable options.
Broader Financial Challenges in Diabetes Treatment
The financial barriers faced by diabetes patients extend beyond the cost of insulin itself. Approximately two-thirds of those who reported underusing insulin also indicated difficulties in affording necessary insulin equipment.
Call to Action for Healthcare Providers
The authors of the study urged regulators and the medical community to take measures aimed at reducing the barriers to accessing affordable insulin for individuals with diabetes. They recommend that physicians proactively screen patients to identify those at greatest risk of cost-related insulin underuse and adjust treatment plans accordingly. By doing so, they hope to alleviate the health-related costs associated with nonadherence and suboptimal management of diabetes.
Author and Reference
Written by Agustin Dominguez Iino, BSc
Reference: Herkert D, Vijayakumar P, Luo J, et al. Cost-Related Insulin Underuse Among Patients With Diabetes. JAMA Intern Med. Published online December 03, 2018. doi:10.1001/jamainternmed.2018.5008